Table 1.
Baseline characteristics of the patients, n (%)
|
Characteristics
|
N = 142
|
| Age, median (IQR) (years) | 62 (35-80) |
| Sex | |
| Male | 114 (80.3) |
| Female | 28 (19.7) |
| ECOG | |
| 0 | 92 (64.8) |
| 1 | 50 (35.2) |
| ≥2 | 0 (0) |
| Premedication | |
| Dexamethasone | 107 (75.4) |
| Antihistamine | 35 (24.6) |
| cTNM stage | |
| I | 1 (0.7) |
| II | 33 (23.2) |
| III | 86 (60.6) |
| IV | 22 (15.5) |
| cT stage | |
| T1 | 0 (0) |
| T2 | 36 (25.4) |
| T3 | 96 (67.6) |
| T4 | 10 (7.0) |
| cN stage | |
| N0 | 20 (14.1) |
| N1 | 54 (38.0) |
| N2 | 51 (35.9) |
| N3 | 17 (12.0) |
The clinical stage was assessed using endoscopy or computed tomography and was classified according to the Union for International Cancer Control tumor–node–metastasis classification, 8th edition. IQR: Interquartile range; cTNM stage: Clinical stage; TNM: Tumor–node–metastasis; ECOG: Eastern Cooperative Oncology Group.